News and Announcements
Alcidion Group Commercialises Miya Platform Throughout Australia & New Zealand & Secures $2.35m Contract with Western Health
- Published August 11, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Alcidion Group Limited (ASX:ALC) is pleased to provide a summary of its progress over the quarter ending 30 June 2017 and report on its cashflow over the same period.
KEY TAKEAWAYS:
- Significant milestones achieved in commercialising the Miya platform throughout Australia and New Zealand.
- Securing of a $AUD2.35m Contract with Western Health, crystallising a long term relationship with Western Health.
- Securing a $NZD1.60m Contract with Mid Central, the Company’s first deployment in New Zealand, paving the way for future engagement with the NZ Ministry of Health and the remaining District Health Boards.
- Securing a contract with the Northern Territory Department of Health to extend Miya Patient Flow across Katherine Hospital in the Northern Territory.
- Hosting initial discussions with Calvary Health Care over the deployment of the Miya platform across the group, with a focus on Revenue Optimisation and Analytics and securing an initial contract to develop a Data Lake for Calvary Health Care.
- Entered into preliminary discussions with North American Strategic Partners, with a view to reciprocal distribution agreements.
- The Company’s quarterly cash and cash equivalents reduced minimally by $114k.
- Strong Cash position with Cash and cash equivalents as of 30 June 2017 of $5.531 million, with minimal debt.
- Reviewed potential acquisition targets, with the view to accelerating the Company’s commercialisation strategy through leveraging cross selling opportunities.
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
